Use of nuclear-localized androgen receptor splice variant 7 protein in CTCs after 1st androgen receptor signaling inhibitor (ARSi) as a predictive biomarker for overall survival on a second ARSi or taxane chemotherapy in metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract

  

Authors:	Scher, H. I.; Graf, R. P.; Hulling, M.; Carbone, E.; Dittamore, R.
Abstract Title:	Use of nuclear-localized androgen receptor splice variant 7 protein in CTCs after 1st androgen receptor signaling inhibitor (ARSi) as a predictive biomarker for overall survival on a second ARSi or taxane chemotherapy in metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title:	43rd ESMO Congress (ESMO 2018)
Journal Title:	Annals of Oncology
Volume:	29
Issue:	Suppl. 8
Meeting Dates:	2018 Oct 19-23
Meeting Location:	Munich, Germany
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2018-10-01
Start Page:	mdy284.045
Language:	English
ACCESSION:	WOS:000459277302018
PROVIDER:	wos
DOI:	10.1093/annonc/mdy284.045
Notes:	Meeting Abstract: 836P -- Appears on page viii292-viii293 of the abstract book -- M. Hullings's last name is misspelled on the original publication -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/145108